Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease pleural effusion disorder
Phenotype C0023418|leukemia
Sentences 10
PubMedID- 22587385 The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
PubMedID- 20463821 The burden of managing pleural effusions in patients with chronic myelogenous leukemia post-imatinib failure: a literature-based economic analysis.
PubMedID- 22812422 pleural effusions in patients with acute leukemia and myelodysplastic syndrome.
PubMedID- 22550016 Acute myeloid leukemia with leukemic pleural effusion.
PubMedID- 24584911 Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapy.
PubMedID- 20191333 Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase.
PubMedID- 22787303 pleural effusion in patients with chronic myeloid leukemia (cml) is a rare occurrence and poorly understood.
PubMedID- 24811835 Recent findings: pleural effusions in patients with leukemia are most often due to infection and to a lesser extent leukemic infiltration of the pleura.
PubMedID- 22687849 Response to low-dose bortezomib in plasma cell leukemia patients with malignant pleural effusion and ascites: a case report and a review of the literature.
PubMedID- 19924787 Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion.

Page: 1